tiprankstipranks
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Switzerland Market
NWRN
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports

Newron Pharmaceuticals SpA (NWRN) Income Statement

4 Followers

Newron Pharmaceuticals SpA Income Statement

Last quarter (Q4 2025), Newron Pharmaceuticals SpA's total revenue was €7.24M, an increase of 103.20% from the same quarter last year. In Q4, Newron Pharmaceuticals SpA's net income was €-13.19M. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 19.13M€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Gross Profit
€ 19.13M€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Operating Expenses
€ 23.81M€ 25.22M€ 20.69M€ 19.40M€ 18.12M
Depreciation and Amortization
€ 173.12K€ 192.00K€ 201.00K€ 202.00K€ 47.00K
EBITDA
€ -4.55M€ 25.94M€ -11.83M€ -13.32M€ -11.92M
Operating Income
€ -4.70M€ 26.17M€ -11.63M€ -13.30M€ -12.36M
Other Income/Expenses
€ -7.66M€ -4.78M€ -4.57M€ -4.17M€ -2.53M
Pretax Income
€ -12.35M€ 21.39M€ -16.20M€ -17.47M€ -14.88M
Net Income
€ -13.33M€ 15.84M€ -16.22M€ -17.49M€ -14.90M
Per Share Metrics
Basic EPS
€ -0.67€ 0.85€ -0.91€ -0.98€ -0.84
Diluted EPS
€ -0.67€ 0.85€ -0.91€ -0.98€ -0.84
Weighted Average Shares Outstanding
 19.96M 18.56M 17.84M 17.84M 17.84M
Weighted Average Shares Outstanding (Diluted)
 19.96M 18.56M 17.84M 17.84M 17.84M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History